Literature DB >> 16153239

Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways.

Oren Froy1.   

Abstract

The immune system consists of innate and adaptive immune responses. The innate immune system confers non-specific protection against a large number of pathogens, hence, serving as the first line of defence. The innate immune system utilizes Toll-like receptors (TLRs) to recognize and bind pathogen-associated molecular patterns (PAMPs). Binding of PAMPs leads to TLR activation, which, in turn, initiates MAPK- or NF-kappaB-dependent cascades that culminate in a proinflammatory response. This response involves the secretion of cytokines, chemokines and broad-spectrum antibacterial substances, such as defensins. Increased defensin synthesis is also mediated by the activation of receptors other than TLRs, such as NOD2, IL-17R and PAR-2. This review summarizes the recently characterized signalling pathways leading to increased defensin synthesis as well as the pathway by which defensins activate TLRs on immature dendritic and memory T cells. Thus, not only do defensins eliminate pathogens, but they also recruit the adaptive immune system in instances of infection and/or inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153239     DOI: 10.1111/j.1462-5822.2005.00590.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  42 in total

1.  Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells.

Authors:  A Rahman; A Fahlgren; C Sundstedt; S Hammarström; A Danielsson; M-L Hammarström
Journal:  Clin Exp Immunol       Date:  2010-10-29       Impact factor: 4.330

Review 2.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Structure-dependent functional properties of human defensin 5.

Authors:  Erik de Leeuw; Scott R Burks; Xiangqun Li; Joseph P Y Kao; Wuyuan Lu
Journal:  FEBS Lett       Date:  2007-01-02       Impact factor: 4.124

Review 4.  The impact of successive infections on the lung microenvironment.

Authors:  Arnaud Didierlaurent; John Goulding; Tracy Hussell
Journal:  Immunology       Date:  2007-12       Impact factor: 7.397

Review 5.  Macrophage activation by endogenous danger signals.

Authors:  X Zhang; D M Mosser
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 6.  Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Authors:  Rajeev K Mehlotra
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

7.  Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells.

Authors:  David Moranta; Verónica Regueiro; Catalina March; Enrique Llobet; Javier Margareto; Eider Larrarte; Eider Larrate; Junkal Garmendia; José A Bengoechea
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  In vivo beta-defensin gene expression in rat gingival epithelium in response to Actinobacillus actinomycetemcomitans infection.

Authors:  A R Kurland; H Schreiner; G Diamond
Journal:  J Periodontal Res       Date:  2006-12       Impact factor: 4.419

9.  Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.

Authors:  Wildeman Zapata; Benigno Rodriguez; Jan Weber; Hernando Estrada; Miguel E Quiñones-Mateu; Peter A Zimermman; Michael M Lederman; Maria T Rugeles
Journal:  Curr HIV Res       Date:  2008-11       Impact factor: 1.581

10.  A preliminary assessment of Toll-like receptor and β-defensin gene polymorphisms in Papua New Guinea - what does it mean for HIV/AIDS?

Authors:  Barne Willie; Janet Gare; Christopher L King; Peter A Zimmerman; Rajeev K Mehlotra
Journal:  P N G Med J       Date:  2017 Mar-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.